michael kors handbags outlet in south africa johannesburg

Based on gene mutations aerobics instructor, they have surprisingly low cholesterol levels. Amgen had similar cholesterol-lowering drugs, also based on this study, is expected to get US approval in August. This drug can reduce cholesterol when used alone statins do not work. Each patient is expected to spend US $ 1.2 million per year, pharmaceutical companies to bring more than one billion US dollars in revenue each year. Pharmaceutical companies also committed to investing in acquisitions and cooperation in order to better carry out research to develop more drugs. Amgen spent $ 415 million in 2012, acquired an Icelandic biotech company, gained vast amounts of data, more than half of adults in Iceland. Genentech collaboration with Silicon Valley startup 23andMe, which sold 1 million users to its $ 99 'saliva kit' (spit kits), users can learn more about their health and family history, more than 80% of users agree its data for research. Genentech will also work to further research foundation Parkinson's disease gene. Regeneration Yuan companies and Pennsylvania's Geisinger Health System (Geisinger Health System) signed an agreement for more than 100,000 volunteers were sequenced. It all depends on the gene sequencing costs drop. From 1990 to 2003, the first human genome took 30 billion dollars. Today, per capita spending dropped to $ 1,000 for carrying out large-scale human genome sequencing and contact Gene and between the symptoms possible. The researchers found that these specific people behind the first gene variant have hidden energy. In 2010, Socrates Papapoulos professor at Leiden University Medical Center in the Netherlands investigated an isolated community, where most residents have overgrown skulls, bones and abnormally large. In the first meeting, he asked if anyone had suffered a car accident. A man hands, said: 'One time my brother and I to cross the road when a Mercedes car rushing, I did not have time to dodge.' Amgen realized that if researchers can simulate the effects of these genetic variations, will be able to promote bone growth, to treat osteoporosis. Suffering from hardening of the bone disease in the absence of a human body can inhibit bone growth protein. The lack of this protein, bone development will have